Source: Reuters

Female Health: BRIEF-Female Health Co says new Tamsulosin DRS formulation advances to stage 2

* The Female Health Company / Veru Healthcare announces successful stage 1 of the clinical trial to evaluate bioequivalence between Tamsulosin DRS and FLOMAX®

Read full article »
Female Health's Competitors | Female Health's News | Female Health's Financials
Stay up-to-date with the latest news on Female Health
Est. Annual Revenue
$25-100M
Est. Employees
100-250
O.B. Parrish's photo - CEO of Female Health

CEO

O.B. Parrish

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Female Health